Dr. David Hunter is an Associate Professor of Neurology at UTHealth Houston and a key leader in the clinical management of neurodegenerative disorders. He completed his medical training at UTHealth Houston, earning his Doctor of Medicine followed by a residency in neurology and a specialized Behavioral Neurology Fellowship. As a cornerstone of the Neurocognitive Disorders Center, Dr. Hunter oversees the day-to-day operations of one of the region's most active dementia clinics, where he supervises a multidisciplinary team and manages the care of nearly 200 patients receiving cutting-edge anti-amyloid therapies.
A veteran of the clinical trial landscape, Dr. Hunter was selected for the prestigious IMPACT-AD program and has served as a sub-investigator for over 40 clinical trials and as site Principal Investigator for four. His expertise spans the design and safety oversight of trials for Alzheimer’s, Parkinson’s, Huntington’s, and Frontotemporal Dementia. He is particularly recognized for his technical proficiency in intrathecal infusion and his long-standing experience with disease-modifying therapies, having worked with anti-amyloid antibodies since their early experimental stages.
Education is a central pillar of Dr. Hunter’s career. He serves as a core interviewer for the UTHealth Houston neurology residency program and is a dedicated mentor to residents, behavioral neurology fellows, and medical students. His commitment to the field extends to the community, where he frequently delivers lectures to both medical professionals and the public to advance the understanding of ADRD treatments.
Dr. Hunter is a Co-Investigator in the HADRC and uses his operational and clinical expertise to harmonize clinical, educational, and research activities across the center’s member institutions. His role is critical in ensuring that the center’s vast patient population is effectively integrated into the research cohort while maintaining the highest standards of clinical safety and regulatory compliance.
